The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silverman, L. B. (2001) · Blood · doi:10.1182/blood.v97.5.1211 · Cited by 865
Cancer. A Comprehensive Treatise: Volume 1. Etiology: Chemical and Physical Carcinogenesis
(1975) · Springer eBooks · doi:10.1007/978-1-4613-4449-0 · Cited by 745
Larson, R., Dodge, R., Burns, C., Lee, E., Stone, R., Schulman, P., Duggan, D., Davey, F., Sobol, R., & Frankel, Sr. (1995) · Blood · doi:10.1182/blood.v85.8.2025.bloodjournal8582025 · Cited by 626
Schrappe, M., Reiter, A., Ludwig, W. D., Harbott, J., Zimmermann, M., Hiddemann, W., Niemeyer, C. M., Henze, G., Feldges, A., Zintl, F., et al. (2000) · PubMed · doi:10.1182/blood.v95.11.3310 · Cited by 602
BROOME, J. D. (1961) · Nature · doi:10.1038/1911114a0 · Cited by 459
Use of ?-asparaginase in childhood ALL
Müller, H. (1998) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00015-8 · Cited by 455
Secondary leukemias induced by topoisomerase-targeted drugs
Felix, C. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00139-0 · Cited by 418
Clavell, L. A., Gelber, R. D., Cohen, H. J., Hitchcock-Bryan, S., Cassady, J. R., Tarbell, N. J., Blattner, S. R., Tantravahi, R., Leavitt, P., & Sallan, S. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151101 · Cited by 416
REGRESSION OF TRANSPLANTED LYMPHOMAS INDUCED IN VIVO BY MEANS OF NORMAL GUINEA PIG SERUM
Kidd, J. G. (1953) · Journal of Experimental Medicine · doi:10.1084/jem.98.6.565 · Cited by 410
Duval, M. (2002) · Blood · doi:10.1182/blood.v99.8.2734 · Cited by 408
Tumor inhibitory effect of l-asparaginase from Escherichia coli
Mashburn, L. T., & Wriston, J. C. (1964) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(64)90032-3 · Cited by 405
EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS
Broome, J. D. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.118.1.99 · Cited by 348
Amylon, M., Shuster, J., Pullen, J., Berard, C., Link, M., Wharam, M., Katz, J., Yu, A., Laver, J., Ravindranath, Y., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401310 · Cited by 347
Comparative pharmacokinetic studies of three asparaginase preparations.
Asselin, B. L., Whitin, J. C., Coppola, D. J., Rupp, I. P., Sallan, S. E., & Cohen, H. J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1780 · Cited by 333
Toxicity of E. coli L-asparaginase in man
Oettgen, H. F., Stephenson, P. A., Schwartz, M. K., Leeper, R. D., Tallal, L., Tan, C. C., Clarkson, B. D., Golbey, R. B., Krakoff, I. H., Karnofsky, D. A., et al. (1970) · Cancer · doi:10.1002/1097-0142(197002)25:2<253::aid-cncr2820250204>3.0.co;2-u · Cited by 290
Inhibition of leukemias in man by L-asparaginase.
Oettgen, H. F., Lj, O., Boyse, E. A., Ha, C., Fs, P., Clarkson, B., Tallal, L., Leeper, R. D., Mk, S., & Kim, J. H. (1967) · PubMed · Cited by 284
L-Asparaginase: Therapeutic and Toxic Effects in Patients with Neoplastic Disease
Haskell, C. M., Canellos, G. P., Leventhal, B. G., Carbone, P. P., Block, J. B., Serpick, A. A., & Selawry, O. S. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911062811902 · Cited by 263
Two L-Asparaginases from Escherichia coli B. Their Separation, Purification, and Antitumor Activity*
Campbell, H. A., Mashburn, L. T., Boyse, E. A., & Old, L. J. (1967) · Biochemistry · doi:10.1021/bi00855a011 · Cited by 230
Peptide and protein drug delivery
(1993) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(93)90342-2 · Cited by 227
Teebor, G. W., & Becker, F. F. (1971) · PubMed · Cited by 219
Boos, J., Werber, G., Ahlke, E., Schulze-Westhoff, P., Nowak-Göttl, U., Würthwein, G., Verspohl, E. J., Ritter, J., & Jürgens, H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00131-1 · Cited by 218
L-Asparaginase and PEG Asparaginase— Past, Present, and Future
Keating, M. J., Holmes, R., Lerner, S., & Ho, D. H. (1993) · Leukemia & Lymphoma · doi:10.3109/10428199309149129 · Cited by 217
Nowak-Göttl, U., Wermes, C., Junker, R., Koch, H.-G., Schobess, R., Fleischhack, G., Schwabe, D., & Ehrenforth, S. (1999) · Blood · doi:10.1182/blood.v93.5.1595 · Cited by 198
Ortega, J. A., Nesbit, M. E., Donaldson, M. H., Hittle, R. E., Weiner, J. M., Karon, M. R., & Hammond, D. (1977) · PubMed · Cited by 186
Toxicity of L-asparaginase in children with advanced leukemia
Land, V. J., Sutow, W. W., Fernbach, D. J., Lane, D. M., & Williams, T. E. (1972) · Cancer · Cited by 184
L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological Studies
CAPIZZI, R. L., BERTINO, J. R., SKEEL, R. T., CREASEY, W. A., ZANES, R., OLAYON, C., PETERSON, R. G., & HANDSCHUMACHER, R. E. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-6-893 · Cited by 180
Riccardi, R., Holcenberg, J. S., Glaubiger, D. L., Wood, J. H., & Poplack, D. G. (1981) · PubMed · Cited by 167
L-Asparaginase and L-Asparagine Metabolism
Cooney, D. A., & Handschumacher, R. E. (1970) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.10.040170.002225 · Cited by 160
EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS
Broome, J. D. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.118.1.121 · Cited by 159
Biochemical and pharmacological studies with asparaginase in man.
Ohnuma, T., Holland, J. F., Freeman, A. I., & Sinks, L. F. (1970) · PubMed · Cited by 155
l-Asparaginase resistance in human leukemia—Asparagine synthetase
Haskell, C. M., & Canellos, G. P. (1969) · Biochemical Pharmacology · doi:10.1016/0006-2952(69)90375-x · Cited by 154
Abshire, T. C., Pollock, B. H., Billett, A. L., Bradley, P., & Buchanan, G. R. (2000) · Blood · doi:10.1182/blood.v96.5.1709 · Cited by 152
Stams, W. A. G. (2003) · Blood · doi:10.1182/blood-2002-08-2446 · Cited by 149
Killander, D., Dohlwitz, A., Engstedt, L., Franzén, S., Gahrton, G., GULLBRING, B., Holm, G., Holmgren, A., Höglund, S., KILLANDER, A., et al. (1976) · Cancer · Cited by 143
REGRESSION OF TRANSPLANTED LYMPHOMAS INDUCED IN VIVO BY MEANS OF NORMAL GUINEA PIG SERUM
Kidd, J. G. (1953) · The Journal of Experimental Medicine · doi:10.1084/jem.98.6.583 · Cited by 132
Hutson, R. G., Kitoh, T., Amador, D. A. M., Cosic, S., Schuster, S. M., & Kilberg, M. S. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.5.c1691 · Cited by 130
Clarkson, B. D., Krakoff, I. H., Burchenal, J. H., Karnofsky, D. A., Golbey, R. B., Dowling, M. D., Oettgen, H. F., & Lipton, A. (1970) · Cancer · Cited by 129
Ertel, I. J., Nesbit, M. E., Hammond, D., Weiner, J. M., & Sather, H. N. (1979) · PubMed · Cited by 126
In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase.
Asselin, B. L., Ryan, D. H., Frantz, C. N., Bernal, S. D., Leavitt, P., Sallan, S. E., & Cohen, H. J. (1989) · PubMed · Cited by 126
Dual Requirement of Walker Carcinosarcoma 256 in vitro for Asparagine and Glutamine
Neuman, R. E., & McCoy, T. A. (1956) · Science · doi:10.1126/science.124.3212.124 · Cited by 125
Nachman, J. B., Sather, H. N., Gaynon, P. S., Lukens, J. N., Wolff, L. J., & Trigg, M. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2222 · Cited by 120
Drug-induced DNA hypermethylation and drug resistance in human tumors.
Nyce, J. W. (1989) · PubMed · Cited by 119
Clinical pharmacology of polyethylene glycol-L-asparaginase.
Ho, D. H., Brown, N. S., Yen, A., Holmes, R., Keating, M. J., Abuchowski, A., Newman, R. A., & Krakoff, I. H. (1986) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08348-5 · Cited by 119
Priest, J. R., Ramsay, N. K. C., Bennett, A. J., Krivit, W. A., & Edson, J. R. (1982) · The Journal of Pediatrics · doi:10.1016/s0022-3476(82)80536-2 · Cited by 118
Escherichia coli L-asparaginase. Catalytic activity and subunit nature
Jackson, R., & Handschumacher, R. E. (1970) · Biochemistry · doi:10.1021/bi00820a013 · Cited by 98
Hann, I. M., Vora, A. J., Richards, S. M., Hill, F. G. H., Gibson, B. E. S., Lilleyman, J. S., Kinsey, S. E., Mitchell, C., & Eden, O. B. (2000) · Leukemia · doi:10.1038/sj.leu.2401704 · Cited by 90
Nesbit, M., Chard, R. L., Evans, A., Karon, M., & Hammond, G. D. (1979) · PubMed · Cited by 88
Purification and properties of asparaginase from Escherichia coli B
Whelan, H. A., & Wriston, J. C. (1969) · Biochemistry · doi:10.1021/bi00834a020 · Cited by 87
Rizzari, C., Citterio, M., Zucchetti, M., Conter, V., Chiesa, R., Colombini, A., Malguzzi, S., Silvestri, D., & D’Incalci, M. (2006) · PubMed · Cited by 83
Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas
Prager, M. D., & Bachynsky, N. (1968) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(68)90028-4 · Cited by 83
Kiriyama, Y., Kubota, M., Takimoto, T., Kitoh, T., Tanizawa, A., Akiyama, Y., & Mikawa, H. (1989) · PubMed · Cited by 80
Yoshimoto, T., Nishimura, H., Saito, Y., Sakurai, K., Kamisaki, Y., Wada, H., Sako, M., Tsujino, G., & Inada, Y. (1986) · PubMed · Cited by 76
Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
Park, Y. K., Abuchowski, A., Davis, S., et al. (1981) · PubMed · Cited by 72
Cheung, N. V., Chau, I. Y., & Coccia, P. F. (1986) · PubMed · Cited by 71
Recent approaches in acute lymphoblastic leukemia in adults
Gökbuget, N., & Hoelzer, D. F. (2002) · Reviews in Clinical and Experimental Hematology · doi:10.1046/j.1468-0734.2002.00068.x · Cited by 66
Wriston, J. C. (1985) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(85)13082-x · Cited by 65
Asparaginase as a drug for treatment of acute lymphoblastic leukaemia.
Gallagher, M. P., Marshall, R. D., & Wilson, R. K. (1989) · PubMed · Cited by 63
Ho, D. H., Whitecar, J. P., Luce, J. K., & Frei, E. (1970) · PubMed · Cited by 61
Acute Deficiency of Thyroxine-Binding Globulin during L-Asparaginase Therapy
Garnick, M. B., & Larsen, P. R. (1979) · New England Journal of Medicine · doi:10.1056/nejm197908023010506 · Cited by 61
L-Asparaginase EC-2 from Escherichia coli. Some substrate specificity characteristics
Campbell, H. A., & Mashburn, L. T. (1969) · Biochemistry · doi:10.1021/bi00837a042 · Cited by 61
L-asparaginase activity in plasma and other biological fluids
Schwartz, M. K., Lash, E. D., Oettgen, H. F., & Tomao, F. A. (1970) · Cancer · Cited by 59
Gilbert, H. J., Blazek, R., Bullman, H., & Minton, N. P. (1986) · Microbiology · doi:10.1099/00221287-132-1-151 · Cited by 56
Organization and Expression of the Cell Cycle Gene, ts11 , That Encodes Asparagine Synthetase
Greco, A., Gong, S. S., Ittmann, M., & Basilico, C. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2350-2359.1989 · Cited by 55
Cremer, P., Lakomek, M., Beck, W., & Prindull, G. (1988) · European Journal of Pediatrics · doi:10.1007/bf00442614 · Cited by 47
Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.
Abuchowski, A., Es, T. V., Palczuk, N. C., McCoy, J. R., & Davis, F. F. (1979) · PubMed · Cited by 43
MacEwen, E. G., ROSENTHAL, R. C., Matus, R. E., Viau, A. T., & Abuchowski, A. (1987) · Cancer · Cited by 41
Favorable remission induction rate with twice weekly doses of L-asparaginase.
Jaffe, N., Traggis, D., Das, L. M. V., Frauenberger, G., Hann, H. W., Kim, B. S., & Bishop, Y. M. M. (1973) · PubMed · Cited by 39
Liposomal palmitoyl-L-asparaginase: characterization and biological activity
Jorge, J. C. S., Perez-Soler, R., Morais, J., & Cruz, M. E. M. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685082 · Cited by 39
Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration
Albertsen, B. K., Jakobsen, P., Schrøder, H. D., Schmiegelow, K., & Carlsen, N. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100286 · Cited by 32
DeLoach, J., Andrews, K., Satterfield, W. C., et al. (1990) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1990.tb00105.x · Cited by 26
Clinical Pharmacology of Intramuscularly Administered l ‐Asparaginase
Ho, D. H., Yap, H. Y., Brown, N. S., Benjamin, R. S., FRIEREICH, E. J., Blumenschein, G. R., & Bodey, G. P. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb01752.x · Cited by 24
Worton, K. S., Kerbel, R. S., & Andrulis, I. L. (1991) · PubMed · Cited by 22
Thyroid Function During L-Asparaginase Therapy in Children with Acute Lymphoblastic Leukemia
Ferster, A., Glinoer, D., Vliet, G. V., & Otten, J. (1992) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199208000-00002 · Cited by 18
Cited by
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Gut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970
“Nutritional modulation of cancer metabolism is also an emerging therapeutic approach, with fasting 68,69 , carbohydrate restriction 70 , amino acid restriction (L-asparaginase 71 , methionine 72 , serine 73 , tyrosine and phenylalanine 74 ) and ketogenic diets 75 under investigation.”
Koppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018) · Cancer Communications · doi:10.1186/s40880-018-0288-x · Cited by 915
Natural compounds for cancer treatment and prevention
Nobili, S., Lippi, D., Witort, E., Donnini, M., Bausi, L., Mini, E., & Capaccioli, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.017 · Cited by 780
Metadata
- Authors
- Narta, U. K., Kanwar, S. S., & Azmi, W.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 61
- Issue
- 3
- Pages
- 208-221
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2080051364
- Cited by
- 384
- References
- 73
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.